Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Lb100
1. 1632032-53-1
2. 0c1juu9s0l
3. Lb100
4. Lb 100
5. Empm
6. (1r,4s)-3-(4-methylpiperazine-1-carbonyl)-7-oxabicyclo[2.2.1]heptane-2-carboxylic Acid
7. 3-((4-methylpiperazin-1-yl)carbonyl)-7-oxabicyclo(2.2.1)heptane-2-carboxylic Acid
8. 7-oxabicyclo(2.2.1)heptane-2-carboxylic Acid, 3-((4-methyl-1-piperazinyl)carbonyl)-, (1r,4s)-rel-
9. 7-oxabicyclo[2.2.1]heptane-2-carboxylic Acid, 3-[(4-methyl-1-piperazinyl)carbonyl]-, (1r,4s)-rel-
10. 3-[(4-methylpiperazin-1-yl)carbonyl]-7-oxabicyclo[2.2.1]heptane-2-carboxylic Acid
11. Unii-0c1juu9s0l
12. Schembl9880148
13. (1r,4s)-lb-100
14. Chembl4297300
15. Gtpl11105
16. Dtxsid201132163
17. Mfcd28167839
18. Db15412
19. Q27895894
20. (1r,4s)-3-[(4-methylpiperazin-1-yl)carbonyl]-7-oxabicyclo[2.2.1]heptane-2-carboxylic Acid
Molecular Weight | 268.31 g/mol |
---|---|
Molecular Formula | C13H20N2O4 |
XLogP3 | -3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 2 |
Exact Mass | 268.14230712 g/mol |
Monoisotopic Mass | 268.14230712 g/mol |
Topological Polar Surface Area | 70.1 Ų |
Heavy Atom Count | 19 |
Formal Charge | 0 |
Complexity | 392 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
ABOUT THIS PAGE
41
PharmaCompass offers a list of LB-100 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right LB-100 manufacturer or LB-100 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred LB-100 manufacturer or LB-100 supplier.
PharmaCompass also assists you with knowing the LB-100 API Price utilized in the formulation of products. LB-100 API Price is not always fixed or binding as the LB-100 Price is obtained through a variety of data sources. The LB-100 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A LB 100 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of LB 100, including repackagers and relabelers. The FDA regulates LB 100 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. LB 100 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A LB 100 supplier is an individual or a company that provides LB 100 active pharmaceutical ingredient (API) or LB 100 finished formulations upon request. The LB 100 suppliers may include LB 100 API manufacturers, exporters, distributors and traders.
LB 100 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of LB 100 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right LB 100 GMP manufacturer or LB 100 GMP API supplier for your needs.
A LB 100 CoA (Certificate of Analysis) is a formal document that attests to LB 100's compliance with LB 100 specifications and serves as a tool for batch-level quality control.
LB 100 CoA mostly includes findings from lab analyses of a specific batch. For each LB 100 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
LB 100 may be tested according to a variety of international standards, such as European Pharmacopoeia (LB 100 EP), LB 100 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (LB 100 USP).